✦ LIBER ✦

Might patients benefit from oral iron therapy following operative treatment of breast carcinoma?

✍ Scribed by R.I Cutress; R Gupta; A Parakh; D Rutter; L Spencer; G.T Royle

Book ID: 117817828
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 69 KB
Volume: 27
Category: Article
ISSN: 0748-7983
DOI: 10.1053/ejso.2001.1205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

242 Heart complication following left-si

242 Heart complication following left-sided breast cancer radiotherapy: a gated CT study aiming to understand which patients might benefit from gated RT treatment

✍ B. Wennberg; M. Hussain; R. Odh; G. Gagliardi; B. Hedlund-Svedjemyr; J. Bjöhle; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Is oral metronomic cyclophosphamide (CTX

Is oral metronomic cyclophosphamide (CTX) an effective palliative treatment for patients with metastatic breast carcinoma (ABC)? experience from a retrospective series of patients

✍ H. Boussen; G. Bellavia; R. Agueli; V. Gebbia 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Breast conservation therapy in the Unite

Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma

✍ DeAnn Lazovich; Cam C. Solomon; David B. Thomas; Roger E. Moe; Emily White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of breast conserv

9. A study to determine the persistent l

9. A study to determine the persistent level of disability following breast cancer treatment at one year and to identify subgroups of patients that might benefit from more intensive physiotherapy using the validated Disabilities of Shoulder and Hand (DASH) questionnaire

✍ Cox, Anna; Adams, Jo; Rainsbury, Dick; Laws, Siobhan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

263 ORAL Doxorubicin and cyclophosphamid

263 ORAL Doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with or without trastuzumab (H) as adjuvant therapy for patients with HER2-positive operable breast cancer (BC): combined analysis of NSABP B-31 and NCCTG N9831

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB